A Multicenter Single-arm Prospective Clinical Study on First-line Treatment of Pancreatic Cancer Liver Metastases With Arterial Infusion Chemotherapy and Embolization Combined With Dual Immune Checkpoint Inhibitors.
Clinical trial NCT07333287 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07333287
- Sponsor
- Shandong Provincial Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-01
- Primary completion
- 2027-02-28
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.